Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/07/2002WO2002088370A2 Autogene nucleic acids encoding a secretable rna polymerase
11/07/2002WO2002088369A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/07/2002WO2002088368A1 Spatial and temporal control of gene expression in the zebrafish using baculovirus
11/07/2002WO2002088367A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002WO2002088365A1 Process for producing coenzyme q¿10?
11/07/2002WO2002088364A1 ss1,3-GALACTOSE TRANSFERASE AND DNA ENCODING THE ENZYME
11/07/2002WO2002088363A2 Regulation of novel human prolyl 4-hydroxylases
11/07/2002WO2002088362A2 Regulation of human prostaglandin-f synthase 1-like protein
11/07/2002WO2002088361A2 Haemophilus influenzae antigens
11/07/2002WO2002088360A2 Haemophilus influenzae antigens
11/07/2002WO2002088359A1 Modification of plant defense, disease/pest resistance and protein storage
11/07/2002WO2002088358A2 Human fibroblast growth factor-related compositions
11/07/2002WO2002088357A2 84242, 8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof
11/07/2002WO2002088356A1 Novel g protein-coupled receptor protein and dna thereof
11/07/2002WO2002088355A1 Novel guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same
11/07/2002WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002WO2002088353A2 Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof
11/07/2002WO2002088351A1 Modified organs and cells for xenotransplantation
11/07/2002WO2002088346A2 A system for inducible expression in eukaryotic cells
11/07/2002WO2002088345A2 Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
11/07/2002WO2002088343A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT)
11/07/2002WO2002088341A2 P450 proteins
11/07/2002WO2002088340A2 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
11/07/2002WO2002088339A2 Bursal disease virus-like particles
11/07/2002WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002WO2002088334A1 Chimeric immunoreceptor useful in treating human cancers
11/07/2002WO2002088328A2 Method for generating highly active human dendritic cells from monocytes
11/07/2002WO2002088325A2 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins
11/07/2002WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002WO2002088321A2 Concentration and purification of analytes using electric fields
11/07/2002WO2002088320A2 rAAV-VECTORED RIBOZYME COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DISEASES
11/07/2002WO2002088319A2 Mini-adenoviral vector and methods of using same
11/07/2002WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002WO2002088316A2 G-protein coupled receptors
11/07/2002WO2002088315A2 Phagemid vectors
11/07/2002WO2002088314A2 Ovary-specific genes and proteins
11/07/2002WO2002088313A2 Novel human nuclear transporters and polynucleotides encoding the same
11/07/2002WO2002088310A2 Cobra gene and uses thereof
11/07/2002WO2002088305A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
11/07/2002WO2002088302A2 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
11/07/2002WO2002088301A2 Increased methionine in transgenic plants expressing mutant cystathionine gamma-synthase
11/07/2002WO2002088296A1 Multichamber device and uses thereof for processing of biological samples
11/07/2002WO2002088186A1 Anti-cd40 monoclonal antibody
11/07/2002WO2002088185A2 Pan-specific monoclonal antibody
11/07/2002WO2002088182A1 Nove g protein-coupled receptor protein and dna thereof
11/07/2002WO2002088181A2 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/07/2002WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002WO2002088179A1 Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same
11/07/2002WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002WO2002088176A2 Genes and proteins for the biosynthesis of polyketides
11/07/2002WO2002088171A2 Combinatorial libraries of monomer domains
11/07/2002WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002WO2002088168A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
11/07/2002WO2002088165A1 Elucidation of gene function
11/07/2002WO2002088163A1 Antisense modulation of interferon gamma receptor 2 expression
11/07/2002WO2002088162A1 Antisense modulation of interferon gamma receptor 1 expression
11/07/2002WO2002088161A1 Method for expression of human interferon alpha 1 in pichia pa storis
11/07/2002WO2002088160A1 Immobilization of oligonucleotides onto solid supports
11/07/2002WO2002088081A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
11/07/2002WO2002087761A1 Method for accelaration and intensification of target-receptor binding and devices therefor
11/07/2002WO2002087625A1 Composite oncolytic herpes virus vectors
11/07/2002WO2002087613A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002WO2002087607A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002WO2002087606A2 Modulators of the hypocretin system and methods of screening therefor
11/07/2002WO2002087594A1 Non-viral vesicle vector for cardiac specific gene delivery
11/07/2002WO2002087541A1 Lipid-based formulations for gene transfer
11/07/2002WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002WO2002087509A2 Colloidal metal compositions and methods
11/07/2002WO2002087507A2 Breast cancer-associated genes and uses thereof
11/07/2002WO2002087503A2 Compositions and methods for treating colorectal polyps and cancer
11/07/2002WO2002087500A2 Viral enzyme activated prototoxophores and use of same to treat viral infections
11/07/2002WO2002087499A2 Cells for detection of enteroviruses
11/07/2002WO2002087496A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
11/07/2002WO2002087419A2 Biological pacemaker
11/07/2002WO2002087411A2 Composite scaffolds and methods using same for generating complex tissue grafts
11/07/2002WO2002087341A1 Novel self-inactivating (sin) lentiviral vectors
11/07/2002WO2002087336A1 Foot and mouth disease virus vaccine
11/07/2002WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002WO2002070721A3 Recombinant dimorphic fungal cell
11/07/2002WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002WO2002066503A3 H. influenzae antigen basb213
11/07/2002WO2002053589A3 Nucleic acid molecules encoding dim interactors and uses therefor
11/07/2002WO2002052016A3 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
11/07/2002WO2002050109A3 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof
11/07/2002WO2002048378A3 Enhancement of freezing tolerance in transgenic plants
11/07/2002WO2002042492A3 Method for detecting protozoae of the genus naegleria
11/07/2002WO2002040699A3 Sampling and storage system for genetic material from tissue
11/07/2002WO2002040684A3 Polynucleotide and polypeptide sequences of human purple acid phosphate
11/07/2002WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002WO2002038785A3 Process for the preparation of trans-carveol
11/07/2002WO2002038745A3 Regulation of mitogen-activated protein kinase (mapk)
11/07/2002WO2002038733A3 A selectable genetic marker for use in pasteurellaceae species
11/07/2002WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002WO2002037077A3 Screening methods based on transcriptional regulation analysis system using transformed cell lines
11/07/2002WO2002036747A3 Peripheral nerve type sodium channels
11/07/2002WO2002034924A3 Expression cassette used for the transgenic expression of nucleic acids in the embryonic epidermis and/or flower of plants
1 ... 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 ... 4023